AGIO compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

AGIOAgios Pharmaceuticals, Inc.

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

AGIOAgios Pharmaceuticals, Inc.

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

AGIOAgios Pharmaceuticals, Inc.

31.38· pre 32.52· delayed

Mkt cap$1.9BRevenue$45MQ2 FY26Revenue$54MFY25

LLYELI Lilly & Co

1,417.89· pre 1,429.30· delayed

Pre-marketNov 5 '26delayed

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

Pre-marketNov 5 '26delayed

AGIOAgios Pharmaceuticals, Inc.

LLYELI Lilly & Co

31.38pre 32.52delayed

Price

1,417.89pre 1,429.30delayed

$1.9B

Mkt cap

$1.3T

Q2 FY26$45M

Revenue

$24.4BQ3 FY26

FY25$54M

Revenue

$65.2BFY25

AGIO31.38vsLLY1,417.89Pre-marketNov 5 '26delayed

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

AGIO: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only AGIO 4

ALNYAlnylamsupplier

—Avanzanite Bioscienceunlistedcustomer

—NewBridge Pharmaceuticals FZ-unlistedcustomer

—Royalty Pharma Investments 2019 ICAVunlistedcustomer

Shared 0

No shared counterparties.

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

25 more · LLY chain ›

Price

rebased to 0%

AGIO, solidLLY, dashed